KODIAK SCIENCES INC. Depreciation
KODIAK SCIENCES INC. (KOD) reported Depreciation of $8.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- KODIAK SCIENCES INC. depreciation for the quarter ending 2026-06-30 was $4.11M, a 10.49% decline year-over-year.
- KODIAK SCIENCES INC. depreciation for the quarter ending 2026-03-31 was $4.11M, a 10.73% decline year-over-year.
- KODIAK SCIENCES INC. depreciation for the quarter ending 2025-12-31 was $4.54M, a 1.77% decline year-over-year.
- KODIAK SCIENCES INC. depreciation for the quarter ending 2025-09-30 was $4.59M, a 2.09% decline year-over-year.
- KODIAK SCIENCES INC. depreciation for fiscal 2025 was $18.33M, a 2.04% decline from fiscal 2024.
- KODIAK SCIENCES INC. depreciation for fiscal 2024 was $18.71M, a 2.25% increase from fiscal 2023.
- KODIAK SCIENCES INC. depreciation for fiscal 2023 was $18.30M, a 382.03% increase from fiscal 2022.
- KODIAK SCIENCES INC. depreciation for fiscal 2022 was $3.80M, a 278.46% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $8.22M 10-Q · filed 2026-08-13 | $12.77M derived: sum of 3 quarters · filed 2026-08-13 | $17.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $4.11M 10-Q · filed 2026-05-07 | $8.65M derived: sum of 2 quarters · filed 2026-05-07 | $13.24M derived: sum of 3 quarters · filed 2026-05-07 | $17.83M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.13M derived: sum of 2 quarters · filed 2026-03-31 | $13.72M derived: sum of 3 quarters · filed 2026-08-13 | $18.33M 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.18M derived: sum of 2 quarters · filed 2026-08-13 | $13.78M 10-Q · filed 2025-11-13 | $18.41M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $9.20M 10-Q · filed 2026-08-13 | $13.82M derived: sum of 3 quarters · filed 2026-08-13 | $18.51M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $4.60M 10-Q · filed 2026-05-07 | $9.23M derived: sum of 2 quarters · filed 2026-05-07 | $13.91M derived: sum of 3 quarters · filed 2026-05-07 | $18.61M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.31M derived: sum of 2 quarters · filed 2026-03-31 | $14.01M derived: sum of 3 quarters · filed 2026-03-31 | $18.71M 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.38M derived: sum of 2 quarters · filed 2025-11-13 | $14.08M 10-Q · filed 2025-11-13 | $18.81M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-06-30 | $4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $9.40M 10-Q · filed 2025-08-13 | $14.13M derived: sum of 3 quarters · filed 2026-03-31 | $19.13M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-03-31 | $4.70M 10-Q · filed 2025-05-14 | $9.43M derived: sum of 2 quarters · filed 2026-03-31 | $14.43M derived: sum of 3 quarters · filed 2026-03-31 | $19.19M derived: sum of 4 quarters · filed 2026-03-31 |
| 2023-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.73M derived: sum of 2 quarters · filed 2026-03-31 | $14.49M derived: sum of 3 quarters · filed 2026-03-31 | $18.30M 10-K · filed 2026-03-31 |
| 2023-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $9.76M derived: sum of 2 quarters · filed 2024-11-14 | $13.57M 10-Q · filed 2024-11-14 | $15.13M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $8.57M 10-Q · filed 2024-08-14 | $10.13M derived: sum of 3 quarters · filed 2025-03-27 | $11.29M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | $3.81M 10-Q · filed 2024-05-15 | $5.37M derived: sum of 2 quarters · filed 2025-03-27 | $6.53M derived: sum of 3 quarters · filed 2025-03-27 | $7.31M derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.72M derived: sum of 2 quarters · filed 2025-03-27 | $3.50M derived: sum of 3 quarters · filed 2025-03-27 | $3.80M 10-K · filed 2025-03-27 |
| 2022-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.94M derived: sum of 2 quarters · filed 2023-11-14 | $2.23M 10-Q · filed 2023-11-14 | $2.52M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $777.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.07M 10-Q · filed 2023-08-14 | $1.36M derived: sum of 3 quarters · filed 2024-03-28 | $1.61M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $298.00K 10-Q · filed 2023-05-15 | $579.00K derived: sum of 2 quarters · filed 2024-03-28 | $835.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.07M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $537.00K derived: sum of 2 quarters · filed 2024-03-28 | $774.00K derived: sum of 3 quarters · filed 2024-03-28 | $1.00M 10-K · filed 2024-03-28 |
| 2021-09-30 | $256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $493.00K derived: sum of 2 quarters · filed 2022-11-09 | $722.00K 10-Q · filed 2022-11-09 | $882.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $466.00K 10-Q · filed 2022-08-09 | $626.00K derived: sum of 3 quarters · filed 2023-03-28 | $727.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $229.00K 10-Q · filed 2022-05-10 | $389.00K derived: sum of 2 quarters · filed 2023-03-28 | $490.00K derived: sum of 3 quarters · filed 2023-03-28 | $586.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $261.00K derived: sum of 2 quarters · filed 2023-03-28 | $357.00K derived: sum of 3 quarters · filed 2023-03-28 | $477.00K 10-K · filed 2023-03-28 |
| 2020-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $197.00K derived: sum of 2 quarters · filed 2021-11-09 | $317.00K 10-Q · filed 2021-11-09 | $450.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $216.00K 10-Q · filed 2021-08-09 | $349.00K derived: sum of 3 quarters · filed 2022-03-01 | $494.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $120.00K 10-Q · filed 2021-05-10 | $253.00K derived: sum of 2 quarters · filed 2022-03-01 | $398.00K derived: sum of 3 quarters · filed 2022-03-01 | $528.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $278.00K derived: sum of 2 quarters · filed 2022-03-01 | $408.00K derived: sum of 3 quarters · filed 2022-03-01 | $538.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $275.00K derived: sum of 2 quarters · filed 2020-11-09 | $405.00K 10-Q · filed 2020-11-09 | $528.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $260.00K 10-Q · filed 2020-08-10 | $383.00K derived: sum of 3 quarters · filed 2021-03-01 | $483.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $130.00K 10-Q · filed 2020-05-11 | $253.00K derived: sum of 2 quarters · filed 2021-03-01 | $353.00K derived: sum of 3 quarters · filed 2021-03-01 | $475.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $223.00K derived: sum of 2 quarters · filed 2021-03-01 | $345.00K derived: sum of 3 quarters · filed 2021-03-01 | $490.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $100.00K 10-Q · filed 2018-11-16 | $222.00K derived: sum of 2 quarters · filed 2019-08-14 | $367.00K 10-Q · filed 2019-11-12 | $530.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $244.00K 10-Q · filed 2019-08-14 | $430.00K derived: sum of 3 quarters · filed 2020-03-16 | $530.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $122.00K 10-Q · filed 2019-05-15 | $308.00K derived: sum of 2 quarters · filed 2020-03-16 | $408.00K derived: sum of 3 quarters · filed 2020-03-16 | |
| 2017-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $286.00K derived: sum of 2 quarters · filed 2020-03-16 | $549.00K 10-K · filed 2020-03-16 | |
| 2017-09-30 | $100.00K 10-Q · filed 2018-11-16 | $363.00K 10-Q · filed 2018-11-16 | ||
| 2016-12-31 | $257.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |